🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer

RecruitingNAAges 18 Years - 80 YearsFemaleQilu Hospital of Shandong University
NCT06656949 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The primary goal of this prospective study is to define the efficacy of the sentinel lymph node biopsy (SLNB) procedure by comparing different method performed in patients with endometrial cancer. The aim of this study is to investigate whether the detection rate of sentinel lymph node (SLN) with two different injection sites may be increased compared to the standard use with single site (cervix) injection in endometrial cancer.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * • 1.Age \>18 and \<80 years old * 2\. The pathological diagnosis was epithelial ovarian cancer * 3.Survival time is expected to exceed 3 months * 4.Signed consent form Exclusion Criteria: * 1\. Patients with myocardial infarction or stroke, or unstable angina pectoris or decompensated heart function * 2.Patients with a history of exhaustion or deep vein thrombosis; * 3\. Liver insufficiency (transaminase \>2.5 times the upper limit of the standard); * 4\. Renal insufficiency (serum muscle liver \>2 times the standard upper limit); * 5\. Pregnancy and perinatal patients; * 6\. History of major organ transplantation and immune disease; * 7\. Psychiatric condition or language barriers * 8\. Alcohol or drug abuser (current or previous) * 9\. Unable or unwilling to sign informed consent or comply with study requirements; * 10\. Patients with other malignant tumors.
💊

What it tests

  • injecting indocyanine green (ICG) dye Intraoperative
📍

Where

1 site
Qilu Hospital，Shandong University
Jinan, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy